Molecular Therapy-Oncolytics

Papers
(The H4-Index of Molecular Therapy-Oncolytics is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Spatiotemporal analysis of induced neural stem cell therapy to overcome advanced glioblastoma recurrence187
Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering143
Ferroptosis gene signature in cholangiocarcinoma121
Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models90
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy70
esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation68
Promoting role of pentraxin-3 in esophageal squamous cell carcinoma67
Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis58
Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 154
Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo54
A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy52
Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML51
Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy50
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model49
Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq48
A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers44
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma42
lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC40
Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy40
Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA40
The miR-23a/27a/24-2 cluster promotes postoperative progression of early-stage non-small cell lung cancer39
Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity36
PROTACs in gastrointestinal cancers36
CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer35
Knockdown of LRRN1 inhibits malignant phenotypes through the regulation of HIF-1α/Notch pathway in pancreatic ductal adenocarcinoma34
AAMP promotes colorectal cancer metastasis by suppressing SMURF2-mediated ubiquitination and degradation of RhoA33
Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma33
In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme32
CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma30
Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response29
0.11625289916992